Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,690.00    40.00 (0.71%)
Bid:
5,690.00
Ask:
5,700.00
Spread: 10.00 (0.176%)
Market Cap: £3.05b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Third Quarter Trading Statement

1 Feb 2018 07:00

RNS Number : 5448D
Cranswick PLC
01 February 2018
 

 

 

1 February 2018

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

Third quarter trading statement

 

Cranswick, a leading UK food producer, today provides an update on trading for the three months to 31 December 2017.

 

Current trading

Total and like-for-like revenue* were both ahead of the prior year. Each of the Group's categories delivered positive volume growth, with this growth underpinned, as anticipated, by a strong performance over the key Christmas trading period. Total export sales were also well ahead.

 

The UK pig price continued to ease during the period, ending the quarter at a similar level to that of a year earlier. This downward trend is being reflected in selling prices.

 

Trading during the third quarter of the financial year was slightly ahead of the Board's expectations.

 

Investment

The Group continues to invest at record levels across its asset base to increase capacity, add new capability and drive further operating efficiencies.

 

Construction of the new Continental Products facility, based at Bury in Lancashire, is well advanced and progressing to plan, with completion expected in the first half of the next financial year. When finished, the site will consolidate production from the Group's two existing Continental Products facilities, lift capacity by approximately 70 per cent, add new capability and drive efficiency improvements on existing product ranges.

 

Plans for the new primary poultry facility in Eye, Suffolk continue to be developed, with construction, subject to receiving planning approval in the coming weeks, expected to begin in quarter one of the next financial year. This class-leading facility, which is scheduled for completion in late 2019, will double existing capacity with further room for expansion. The facility will incorporate the highest animal welfare standards and latest generation production techniques and equipment to drive operational efficiency gains.

 

Financial position

During the period, the Group extended its banking facility for a further 12 months on existing terms. The agreement, which now extends to November 2022 with the potential to extend for a further year, comprises a revolving credit facility of £160 million, including a committed overdraft of £20 million. This unsecured facility supports the Group's sound financial position and provides significant headroom for future growth.

 

Net debt increased during the quarter, albeit it was below the level at the same stage last year, reflecting the anticipated seasonal increase in working capital and ongoing capital expenditure.

 

Outlook

With experienced management at all levels of the Group, a strong range of products, a well-invested asset base and a robust financial position, the Board is confident in both the prospects for the remainder of the current financial year and the continued long-term success and development of the business.

 

Preliminary results

The Company's next scheduled comment on trading will be the preliminary results announcement on 22 May 2018.

 

Enquiries:

 

Cranswick plc

01482 372 000

Mark Bottomley, Finance Director

Powerscourt

020 7250 1446

Nick Dibden / Lisa Kavanagh

cranswick@powerscourt-group.com

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, premium fresh and cooked poultry, charcuterie and pastry products. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2017 showed revenue from continuing operations of £1,245m and profit before tax on the same basis of £77.5m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement contains certain forward-looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

* Like-for-like revenue excludes the contribution from acquired businesses in the current year prior to the first anniversary following the date of acquisition.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDLRILVIT
Date   Source Headline
18th May 20217:00 amRNSChange of Chairmanship
18th May 20217:00 amRNSPreliminary Results
4th May 20213:56 pmRNSTotal Voting Rights
1st Apr 20213:32 pmRNSBlock listing Interim Review
1st Apr 20213:31 pmRNSBlock listing Interim Review
1st Apr 20213:29 pmRNSTotal Voting Rights
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:47 amRNSDirector/PDMR Shareholding
23rd Mar 20216:03 pmRNSHolding(s) in Company
23rd Mar 20219:07 amRNSDirector/PDMR Shareholding
23rd Mar 20219:06 amRNSDirector/PDMR Shareholding
16th Mar 20211:29 pmRNSDirector/PDMR Shareholding
16th Mar 20218:30 amRNSNon-Executive Director Appointment
2nd Mar 20217:30 amRNSDirector/PDMR Shareholding
15th Feb 20212:59 pmRNSDirector/PDMR Shareholding
4th Feb 20217:00 amRNSThird Quarter Trading Statement
1st Feb 202110:29 amRNSTotal Voting Rights
28th Jan 20213:01 pmRNSAdditional Listing
28th Jan 20217:44 amRNSAdditional Listing
25th Jan 202112:31 pmRNSDirectorship
13th Jan 20218:38 amRNSHolding(s) in Company
4th Jan 20212:19 pmRNSTotal Voting Rights
24th Dec 20207:51 amRNSHolding(s) in Company
24th Dec 20207:49 amRNSDividend Announcement
17th Dec 20207:00 amRNSWithdrawal from Acquisition Process
16th Dec 202011:22 amRNSResponse to Press Speculation
11th Dec 20208:39 amRNSHolding(s) in Company
1st Dec 20208:26 amRNSTotal Voting Rights
24th Nov 20203:45 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSInterim Results
18th Nov 20204:37 pmRNSHolding(s) in Company
3rd Nov 20205:15 pmRNSTotal Voting Rights
27th Oct 20202:55 pmRNSHolding(s) in Company
27th Oct 20202:51 pmRNSHolding(s) in Company
26th Oct 202011:51 amRNSHolding(s) in Company
1st Oct 20201:54 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20201:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20201:49 pmRNSTotal Voting Rights
25th Sep 20202:34 pmRNSHolding(s) in Company
2nd Sep 20202:01 pmRNSAdditional Listing
1st Sep 202011:45 amRNSDirector/PDMR Shareholding
1st Sep 202011:18 amRNSTotal Voting Rights
17th Aug 20202:57 pmRNSPoll Result for 2020 Annual General Meeting
17th Aug 20207:00 amRNSFirst quarter trading statement
11th Aug 20207:00 amRNSAnnual General Meeting update
3rd Aug 20202:30 pmRNSTotal Voting Rights
31st Jul 202012:26 pmRNSDirector/PDMR Shareholding
31st Jul 202012:26 pmRNSDirector/PDMR Shareholding
31st Jul 202012:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.